EMA Guidance On Registry-Based Studies Due This Month

The European Medicines Agency is planning an October workshop to discuss its new guideline on registry-based studies and to discuss recent experience on aspects such as the use of a large registry for clinical trials.

Index
Patient registries can play an important role in monitoring drug safety • Source: Shutterstock

More from Clinical Trials

More from R&D